Financial Performance - Revenue for Q3 2024 reached ¥733,667,987.02, an increase of 9.42% compared to the same period last year[2] - Net profit attributable to shareholders was ¥8,112,722.98, a decrease of 76.84% year-over-year[2] - Net profit excluding non-recurring gains and losses was ¥2,155,073.76, down 94.08% from the previous year[2] - Basic earnings per share were ¥0.06, down 77.78% year-over-year[2] - Net profit for Q3 2024 was ¥33,407,082.55, a decrease of 58.0% from ¥79,509,818.72 in Q3 2023[17] - The total comprehensive income attributable to the parent company for Q3 2024 was CNY 33,390,653.92, compared to CNY 79,444,208.16 in the same period last year, representing a significant decrease[18] - The basic and diluted earnings per share for Q3 2024 were both CNY 0.24, down from CNY 0.70 in the same period last year[18] Cash Flow - Cash flow from operating activities showed a net outflow of ¥48,760,213.31, a decline of 382.15% compared to the same period last year[5] - The net cash flow from operating activities for Q3 2024 was negative CNY 48,760,213.31, a decline from positive CNY 17,281,463.78 in the previous year[20] - Cash inflow from operating activities totaled CNY 2,223,149,459.10, up from CNY 1,823,550,175.88 year-on-year[19] - Cash outflow from operating activities increased to CNY 2,271,909,672.41, compared to CNY 1,806,268,712.10 in the previous year[19] - The net cash flow from investing activities was CNY 202,748,008.83, a recovery from a negative CNY 522,078,268.69 in the same period last year[20] - The company received CNY 2,231,250,000.00 in cash from investment recoveries during the reporting period[20] - The company paid CNY 330,129,306.55 for the purchase of fixed assets, intangible assets, and other long-term assets[20] - The company reported a cash inflow of CNY 27,000,000.00 from borrowings in Q3 2024, down from CNY 39,000,000.00 in the previous year[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,649,491,461.41, a decrease of 4.58% from the end of the previous year[2] - The total assets as of Q3 2024 amounted to ¥1,649,491,461.41, a decrease from ¥1,728,733,312.73 at the end of Q3 2023[15] - The total liabilities for Q3 2024 were ¥239,449,536.89, down from ¥282,705,726.48 in Q3 2023, indicating a reduction of 15.3%[15] - The total current assets decreased to ¥954,708,602.12 from ¥1,310,905,256.77, indicating a decline of about 27.1%[13] - Accounts receivable rose to ¥183,247,074.62 from ¥149,292,179.33, reflecting an increase of approximately 22.7%[13] - The company reported a significant increase in inventory, which reached ¥156,668,308.84 compared to ¥151,270,703.10, marking a growth of about 3.0%[13] - The company reported a decrease in accounts payable to ¥97,621,694.68 in Q3 2024 from ¥136,901,475.40 in Q3 2023, a decline of 28.7%[15] - Deferred income tax assets increased to ¥6,259,065.18 in Q3 2024 from ¥3,523,640.24 in Q3 2023, reflecting an increase of 77.0%[15] Shareholder Information - The total number of common shareholders at the end of the reporting period was 11,921[6] - The total number of shares held by the top 10 shareholders includes 62,266,851 shares held by Jiangsu Changshun Group Co., Ltd., representing 5% or more of the total shares[11] - The total number of restricted shares at the end of the period is 86,722,976, down from 106,934,734 at the beginning of the period[12] - The company has released 7,812,500 shares from lock-up, which were previously held by Shanghai Chuangfeng Xinhui Venture Capital Management Co., Ltd. and its affiliates[11] Operational Insights - The company reported a significant decline in gross profit margin due to market competition and rising raw material prices[5] - Research and development expenses increased to ¥12,618,289.39 in Q3 2024, compared to ¥8,156,905.11 in Q3 2023, marking a rise of 54.0%[17] - The company has no new product launches or technological developments reported in this quarter[12] - There are no significant mergers or acquisitions mentioned in the current report[12] - The company has not provided specific future guidance or market expansion strategies in this quarter[12]
长华化学(301518) - 2024 Q3 - 季度财报